salt: Clinical Trials

12 trials of salt, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 1 active not recruiting, 1 terminated. 7 Not applicable, 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Unknown 2
Phase 22Terminated 1, Withdrawn 1
Phase 42Active not recruiting 1, Completed 1

Follow salt: new trials by email Literature Review of salt trials Research Report on salt

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immediate Pressor Response to Oral Salt
salt - High Blood Pressure
Not applicableUnknownMulungushi University3002023-07-072024-01-26
Salt Intake, Microbiota, Immune Response and Endothelial Function in Hypertension
Low salt diet plus sodium chloride supplements, Low salt diet plus placebo - Hypertension
Not applicableUnknownHospital Clínico Universitario de Valladolid252020-12-012021-02-12
Dietary Salt in Rheumatoid Arthritis
salt - Rheumatoid Arthritis
Not applicableCompletedVanderbilt University Medical Center182020-01-022026-07-30
Intralipid® 20% for Reversal of Local Anesthetics
Lidocaine 2%, Lidocaine 1%, Bupivacaine 0.25% - Anesthesia, Local
Phase 4Active not recruitingHospital for Special Surgery, New York182019-07-262025-12-08
Salt-sensitive Hypertension Study in Lantian County
salt - Hypertension
UnknownFirst Affiliated Hospital Xi'an Jiaotong University702017-02-282017-02-27
Randomized Study on Salt Intake and Energy Metabolism
Salt, Placebo - Healthy
Not applicableCompletedCharite University, Berlin, Germany402017-01-012022-07-11
Salt Intake and Lactobacillus Abundance
Probiotics, Salt - Healthy Volunteers, Probiotics
Not applicableCompletedCharite University, Berlin, Germany82016-11-012022-07-11
Stimulating Language in Subacute StrokE
A-tDCS (1 mA), SALT, Sham - Stroke
Not applicableCompletedJohns Hopkins University582016-06-152023-03-10
Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis
Halotherapy, Placebo - Inverse Psoriasis, Sebopsoriasis
Phase 2WithdrawnTecno Sun SRL2012-03-012014-11-18
Efficacy of Aerosal® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases
Halotherapy, Placebo - Sleep Apnea, Obstructive
Phase 2TerminatedTecno Sun SRL452012-02-012012-11-08
Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass.
Placebo: sterile normal saline, Marcaine - Pain, Obesity
Phase 4CompletedFunch-Jensen, Peter, M.D., D.M.Sc.802011-02-012014-03-26
Lidocaine and Neuroma Pain Related Modalities
Lidocaine (Xylocaine), NaCl - Neuropathic Pain
Not applicableCompletedUppsala University162010-04-012014-11-24

Conditions studied

Hypertension (3)  ·  Aphasia (1)  ·  Arthritis, Rheumatoid (1)  ·  Hypertrophy (1)  ·  Language (1)  ·  Neuralgia (1)  ·  Obesity (1)  ·  Pain (1)  ·  Proteinuria (1)  ·  Psoriasis (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Apnea, Obstructive (1)  ·  Stroke (1)

Sponsors

Charite University, Berlin, Germany (2)  ·  Tecno Sun SRL (2)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Funch-Jensen, Peter, M.D., D.M.Sc. (1)  ·  Hospital Clínico Universitario de Valladolid (1)  ·  Hospital for Special Surgery, New York (1)  ·  Johns Hopkins University (1)  ·  Mulungushi University (1)  ·  Uppsala University (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Germany (2)  ·  Italy (2)  ·  Denmark (1)  ·  Spain (1)  ·  Zambia (1)

Top investigators

Anja Maehler, PhD (1)  ·  Argye B Hillis-Trupe, MD, MA (1)  ·  Armando Coca, MD, MSc, phD (1)  ·  Charles M Stein, MBChB (1)  ·  Jianjun Mu, doctor (1)  ·  Luigi Naldi, MD (1)  ·  Matteo Gelardi, MD (1)  ·  Peter Funch-Jensen, D.M.Sc. (1)  ·  Stavros Memtsoudis, MD/PhD (1)

Results publications

PMID 22978814, PMID 23059770, PMID 24041858, PMID 25058146, PMID 28985241, PMID 33375942, PMID 33783375, PMID 35057434, PMID 36912144, PMID 37592860, PMID 38281579

NIH funding

R01HL140145 (1)